Lam Research Co. (NASDAQ:LRCX – Free Report) – Stock analysts at Zacks Research decreased their Q3 2025 earnings per share estimates for shares of Lam Research in a research note issued on Wednesday, November 13th. Zacks Research analyst R. Department now forecasts that the semiconductor company will earn $0.86 per share for the quarter, down from their prior estimate of $0.88. The consensus estimate for Lam Research’s current full-year earnings is $3.52 per share. Zacks Research also issued estimates for Lam Research’s Q1 2026 earnings at $0.97 EPS, Q2 2026 earnings at $1.01 EPS, FY2026 earnings at $4.08 EPS and FY2027 earnings at $4.73 EPS.
Lam Research (NASDAQ:LRCX – Get Free Report) last issued its quarterly earnings data on Wednesday, October 23rd. The semiconductor company reported $0.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.81 by $0.05. Lam Research had a net margin of 26.02% and a return on equity of 50.60%. The firm had revenue of $4.17 billion during the quarter, compared to the consensus estimate of $4.06 billion. During the same period last year, the business posted $6.85 earnings per share. The business’s revenue for the quarter was up 19.7% compared to the same quarter last year.
Check Out Our Latest Report on LRCX
Lam Research Stock Performance
LRCX opened at $70.05 on Friday. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.53 and a quick ratio of 1.74. The business has a fifty day simple moving average of $77.23 and a 200 day simple moving average of $87.99. Lam Research has a 1 year low of $68.72 and a 1 year high of $113.00. The company has a market capitalization of $90.13 billion, a PE ratio of 22.67, a price-to-earnings-growth ratio of 1.17 and a beta of 1.48.
Lam Research Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 8th. Investors of record on Wednesday, December 11th will be given a $0.23 dividend. This represents a $0.92 dividend on an annualized basis and a yield of 1.31%. The ex-dividend date of this dividend is Wednesday, December 11th. Lam Research’s payout ratio is 29.77%.
Insider Buying and Selling
In other Lam Research news, CAO Christina Correia sold 647 shares of the business’s stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $817.51, for a total transaction of $528,928.97. Following the completion of the sale, the chief accounting officer now owns 4,267 shares in the company, valued at approximately $3,488,315.17. The trade was a 13.17 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.29% of the stock is owned by company insiders.
Institutional Inflows and Outflows
A number of hedge funds have recently made changes to their positions in the business. CarsonAllaria Wealth Management Ltd. bought a new position in Lam Research in the 2nd quarter valued at about $32,000. RFP Financial Group LLC raised its stake in shares of Lam Research by 52.2% in the second quarter. RFP Financial Group LLC now owns 35 shares of the semiconductor company’s stock worth $37,000 after purchasing an additional 12 shares during the last quarter. Hobbs Group Advisors LLC bought a new position in shares of Lam Research in the second quarter valued at approximately $40,000. Country Trust Bank purchased a new position in shares of Lam Research during the second quarter valued at approximately $43,000. Finally, MFA Wealth Advisors LLC bought a new stake in Lam Research during the second quarter worth $45,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.
About Lam Research
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Further Reading
- Five stocks we like better than Lam Research
- Conference Calls and Individual Investors
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Health Care Stocks Explained: Why You Might Want to Invest
- Time to Load Up on Home Builders?
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.